Chilvers Geoffrey Spencer, Porter Graham
ENT Department, St Michael's Hospital, University Hospitals Bristol Trust, Bristol, UK.
BMJ Case Rep. 2014 Aug 5;2014:bcr2014205248. doi: 10.1136/bcr-2014-205248.
This is the first case report of a patient with acquired von Willebrand's disease (AvWD) secondary to epithelial myoepithelial carcinoma (EMC) of the parotid salivary gland. This patient presented to haematology following an abnormal bleeding episode with von Willebrand factor Ristocetin cofactor (VWF:RCo) <5% and VWF:Ag 13%. He was diagnosed with AvWD. At the same time he was found to have a left parotid lump which was excised following a multidisciplinary team meeting. This was histologically reported as an EMC. Following excision, unusually this patient's AvWD did not resolve. Extensive investigation looking for other causes of the AvWD did not reveal any other potential cause; therefore, due to the similar timing of onset of both pathologies it is felt that the AvWD in this case is secondary to the EMC. This case report highlights the presentation, investigation and management of AvWD and parotid lumps as well as discussing proposed pathophysiological mechanisms for AvWD.
这是首例关于腮腺上皮-肌上皮癌(EMC)继发获得性血管性血友病(AvWD)患者的病例报告。该患者在一次异常出血事件后就诊于血液科,当时血管性血友病因子瑞斯托霉素辅因子(VWF:RCo)<5%,VWF:Ag为13%。他被诊断为AvWD。与此同时,发现他左侧腮腺有一个肿块,在多学科团队会诊后将其切除。组织学报告显示为EMC。切除术后,该患者的AvWD并未像通常那样缓解。对AvWD的其他病因进行的广泛调查未发现任何其他潜在病因;因此,鉴于两种病症发病时间相近,认为该病例中的AvWD继发于EMC。本病例报告强调了AvWD和腮腺肿块的临床表现、检查及管理,同时讨论了AvWD的拟议病理生理机制。